
2 mg/mL · 5 mL vial
BPC-157 Injection
For the men whose recovery has stopped keeping pace with their training.
- Studied in the repair of tendon, ligament, muscle, and gut tissue
- Subcutaneous injection, typically once daily
- Single-ingredient, compounded by a licensed U.S. pharmacy
The BPC-157 protocol will soon be available for purchase.
Join the waitlist and we'll email you when ordering opens.
Unsubscribe at any time.
US board-certified physician review
A board-certified physician builds your protocol.
US-licensed 503A pharmacy
Pharmaceutical-grade purity, prescribed by your physician.
Shipped discreetly to your door
Subscription billed monthly. Cancel anytime.
How BPC-157 works
BPC-157 is a 15-amino-acid peptide, modeled on a protein found in gastric juice, that has been studied for its role in tissue repair signaling.
BPC-157 (Body Protection Compound-157) is a synthetic sequence of 15 amino acids modeled on a fragment of a protective protein found in human gastric juice. The compounded injectable uses the acetate form of the peptide, delivered subcutaneously.
In preclinical research, BPC-157 has been studied for its effects on angiogenesis (the formation of new blood vessels), growth factor expression, and the migration of the cells involved in repairing tendon, ligament, and muscle tissue. The same body of research has examined its effects on the lining of the gut.
Why BPC-157
BPC-157 is one of the most discussed recovery peptides among men who train seriously, and for years it was available only through unregulated research-chemical sellers: no prescription, no physician, and no pharmacy standards behind the vial.
EdgeRx offers BPC-157 as a single-ingredient protocol, prescribed by a U.S. board-certified physician for you specifically and compounded by a licensed U.S. 503A pharmacy from documented pharmaceutical-grade ingredients. No blends, no stacks, no mystery vials.
What to expect
BPC-157 is typically run as a daily subcutaneous protocol over several weeks. Because human data is limited, your physician sets expectations with you based on your goals and history rather than a fixed timeline.
- A short daily routine with an insulin-sized needle
- A patient-specific prescription with physician oversight throughout
- Cold-chain shipping from the compounding pharmacy to your door
- Clear guidance on storage, handling, and what to report
How you take it
The routine
A small subcutaneous injection, typically once daily, with an insulin-sized needle. Most men take it at the same time each day.
Starting dose
Set by your prescribing physician after your medical assessment.
Storage
Refrigerated. Ships cold-chain from the pharmacy; keep it in the refrigerator and follow the beyond-use date on the label.
Cycle length
Typically run in courses of several weeks, with your physician deciding whether and when to repeat.
Questions
Join the BPC-157 waitlist
The BPC-157 protocol will soon be available for purchase.
Join the waitlist and we'll email you when ordering opens.
Unsubscribe at any time.
BPC-157 is not an FDA-approved drug and has not been evaluated by the FDA for safety or effectiveness. On EdgeRx it is prepared as a single-ingredient compounded drug product by a licensed U.S. 503A compounding pharmacy for an individual patient on the basis of a physician's prescription. Compounded drug products are not reviewed or approved by the FDA. Most published research on this compound comes from animal and cell studies, and controlled human trials are limited. This page describes the compound and how the EdgeRx protocol is structured; it does not claim that BPC-157 treats, cures, or prevents any disease. Tell your physician about every medication, supplement, and diagnosis before starting any protocol.
